Molecular biology of viral hepatitis and hepatocellular carcinoma.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 8275664)

Published in Compr Ther on January 01, 1993

Authors

P H Hayashi1, J B Zeldis

Author Affiliations

1: GI Division University of California, Davis Medical Center, Sacramento.

Articles by these authors

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma. Leukemia (2009) 2.25

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease. Gastroenterology (1999) 2.16

Orientation of prophage Mu. Virology (1973) 1.67

Thalidomide and its analogues inhibit lipopolysaccharide-mediated Iinduction of cyclooxygenase-2. Clin Cancer Res (2001) 1.53

An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast. Curr Med Res Opin (2008) 1.49

Cationic lipid enhances in vitro receptor-mediated transfection. Am J Med Sci (1994) 1.47

Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J Infect Dis (1992) 1.45

Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region. J Virol (1987) 1.42

Ranitidine: a new H2-receptor antagonist. N Engl J Med (1983) 1.24

Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis. Gastroenterology (1988) 1.13

In vitro hepatitis B virus infection of human bone marrow cells. J Clin Invest (1986) 1.11

Aplastic anemia and non-A, non-B hepatitis. Am J Med (1983) 1.06

Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope. Proc Natl Acad Sci U S A (1992) 1.05

Recent clinical studies of the immunomodulatory drug (IMiD) lenalidomide. Br J Cancer (2005) 1.01

Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C. Hepatology (1993) 0.99

Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine. Transfusion (1993) 0.96

The location and expression of idiotypic determinants in the immunoglobulin variable region--II. Chain location of variable region determinants. Mol Immunol (1979) 0.94

Hepatitis C virus in blood samples from volunteer donors. J Clin Microbiol (1993) 0.93

Decreased phorbol myristate acetate-induced release of tumor necrosis factor-alpha and interleukin-1 beta from peripheral blood monocytes of patients chronically infected with hepatitis C virus. J Infect Dis (1996) 0.93

Hepatitis C in patients undergoing liver transplantation. Ann Intern Med (1991) 0.92

Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents. J Adolesc Health (1995) 0.91

Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group. Am J Gastroenterol (1998) 0.90

Correlation of HBV DNA and monoclonal reactivity to HBsAg in serum of patients with HBV infection. J Virol Methods (1986) 0.90

Sequential effects of interleukin 2-diphtheria toxin fusion protein on T-cell activation. Proc Natl Acad Sci U S A (1989) 0.88

In vitro inhibition of hemopoietic cell line growth by hepatitis B virus. J Virol (1990) 0.87

Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies. Transplantation (1987) 0.86

The location and expression of idiotypic determinants in the immunoglobulin variable region--III. Expression of the protein 315 and 460 idiotypic determinants in mouse anti-Dnp antibodies. Mol Immunol (1979) 0.86

Chronic hepatitis B virus infection in an anti-HBc-nonreactive blood donor: variant virus or defective immune response? Hepatology (1992) 0.84

The location and expression of idiotypic determinants in the immunoglobulin variable region--I. Characterization of antibodies directed against the variable region of mouse myeloma immunoglobulins 315 and 460. Mol Immunol (1979) 0.83

Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus. J Med Virol (1991) 0.83

A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease. Aliment Pharmacol Ther (2007) 0.83

Evaluation of the role of hepatitis C virus in biliary atresia. Pediatr Infect Dis J (1994) 0.82

The long-term outcome of hepatitis B infection in hemodialysis patients. Am J Kidney Dis (1988) 0.81

Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide. J Thromb Haemost (2006) 0.81

Serologic and DNA follow-up data from HBsAg-positive patients treated with orthotopic liver transplantation. Transplantation (1991) 0.80

Hepatitis C virus infection in acquired aplastic anemia. Am J Hematol (1998) 0.80

Primary hepatocellular carcinoma following nonspecific non-B hepatitis with tumor DNA negative for HBV DNA. Dig Dis Sci (1987) 0.78

Preliminary evidence that azidothymidine does not affect hepatitis B virus replication in acquired immunodeficiency syndrome (AIDS) patients. J Med Virol (1989) 0.78

Hepatitis C virus pathogenicity: the corner pieces of the jigsaw puzzle are found. Gastroenterology (1994) 0.77

Hepatic diseases in the elderly. Gastroenterol Clin North Am (1990) 0.76

Hepatitis C in liver transplant recipients. Transplant Proc (1991) 0.76

Polylysine enhances cationic liposome-mediated transfection of the hepatoblastoma cell line Hep G2. Biotechnol Appl Biochem (1996) 0.76

Absence of hepatitis B and C viruses in pediatric idiopathic membranoproliferative glomerulonephritis. Pediatr Nephrol (1995) 0.76

HIV-related skin diseases. Lancet (1996) 0.75

Pregnancy and inflammatory bowel disease. West J Med (1989) 0.75

Seronegative hepatitis C virus liver failure following transplantation of a cadaveric heart. West J Med (1994) 0.75

Effect of dengue virus on hematopoietic progenitors. Blood (1990) 0.75

Reply: Diagnosis of viral hepatitis. Ann Saudi Med (1995) 0.75

The development of a mutation in the precore region of the hepatitis B virus in a chronically infected individual. Gastroenterology (1994) 0.75

Gastrointestinal illness in managed care: healthcare utilization and costs. Am J Manag Care (1997) 0.75

Polymerase chain reaction in gastroenterology. J Clin Gastroenterol (1993) 0.75

Infection of a leukemic cell line (K562) by hepatitis B virus induces cell growth inhibition. J Hepatol (1993) 0.75

Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassay. Viral Immunol (1993) 0.75

Hepatitis in an adult with rubella. Am J Med (1985) 0.75

Fulminant hepatic failure following bone marrow transplantation for hepatitis-associated aplastic anemia. Bone Marrow Transplant (1990) 0.75

Carnot Malade. Lithograph by Henri de Toulouse-Lautrec Paris, 1893; G. Ondet, printer. New Haven, Yale Medical Library, Clements C. Fry collection. J Hist Med Allied Sci (1977) 0.75